Get started
Rallybio CorporationRallybio CorporationRallybio Corporation

Rallybio Corporation

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

RLYB chart


Full chart

RLYB upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪37.92 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−1.5898 USD
Net income (FY)
‪−74.56 M‬ USD
Revenue (FY)
0.00 USD
Shares float
‪20.18 M‬
Beta (1Y)
0.82

Employees


Employees (FY)
43
Change (1Y)
+2 +4.88%
Revenue / Employee (1Y)
0.00 USD
Net income / Employee (1Y)
‪−1.73 M‬ USD

About Rallybio Corporation


Sector
Health Technology
Industry
Biotechnology
CEO
Stephen Uden
Website
rallybio.com
Headquarters
New Haven
Founded
2018
FIGI
BBG011PFKF54
Rallybio Corp. engages in the identification, research and development, and manufacture of clinical biotechnology products and therapies for severe and rare diseases. Its product candidates focus on the areas of fetal and neonatal disorders, hematology, immuno-inflammation, and metabolic disease. The company was founded by Martin W. Mackay, Stephen Uden, and Jeffrey M. Fryer in January 2018 and is headquartered in New Haven, CT.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

RLYB news



Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of RLYB is 0.9290 USD — it has decreased by −0.44% in the past 24 hours. Watch Rallybio Corporation stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Rallybio Corporation stocks are traded under the ticker RLYB.
RLYB stock has fallen by −5.55% compared to the previous week, the month change is a −14.96% fall, over the last year Rallybio Corporation has showed a −63.43% decrease.
We've gathered analysts' opinions on Rallybio Corporation future price: according to them, RLYB price has a max estimate of 13.00 USD and a min estimate of 5.00 USD. Watch RLYB chart and read a more detailed Rallybio Corporation stock forecast: see what analysts think of Rallybio Corporation and suggest that you do with its stocks.
RLYB reached its all-time high on Jul 30, 2021 with the price of 25.7800 USD, and its all-time low was 0.8410 USD and was reached on Dec 24, 2024. View more price dynamics on RLYB chart.
See other stocks reaching their highest and lowest prices.
RLYB stock is 6.65% volatile and has beta coefficient of 0.82. Track Rallybio Corporation stock price on the chart and check out the list of the most volatile stocks — is Rallybio Corporation there?
Today Rallybio Corporation has the market capitalization of ‪37.92 M‬, it has decreased by −12.20% over the last week.
Yes, you can track Rallybio Corporation financials in yearly and quarterly reports right on TradingView.
Rallybio Corporation is going to release the next earnings report on Mar 18, 2025. Keep track of upcoming events with our Earnings Calendar.
RLYB earnings for the last quarter are −0.26 USD per share, whereas the estimation was −0.35 USD resulting in a 26.14% surprise. The estimated earnings for the next quarter are −0.29 USD per share. See more details about Rallybio Corporation earnings.
Rallybio Corporation revenue for the last quarter amounts to ‪299.00 K‬ USD, despite the estimated figure of ‪75.00 K‬ USD. In the next quarter, revenue is expected to reach ‪149.50 K‬ USD.
RLYB net income for the last quarter is ‪−11.47 M‬ USD, while the quarter before that showed ‪−16.24 M‬ USD of net income which accounts for 29.38% change. Track more Rallybio Corporation financial stats to get the full picture.
No, RLYB doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 30, 2024, the company has 43.00 employees. See our rating of the largest employees — is Rallybio Corporation on this list?
Like other stocks, RLYB shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Rallybio Corporation stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Rallybio Corporation technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Rallybio Corporation stock shows the sell signal. See more of Rallybio Corporation technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.